| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/03/2000 | EP0754043B1 Inhibition of smooth muscle cell migration by (r)-amlodipine |
| 05/03/2000 | EP0743940B1 New compounds with analgesic and local anaesthetic effect |
| 05/03/2000 | EP0719767B1 Succinamic acid compound, process for producing the same, and use thereof |
| 05/03/2000 | EP0711151B1 Particles with modified physicochemical properties, their preparation and uses |
| 05/03/2000 | EP0652768B1 A pharmaceutical preparation for the synergistic activation of natural killer cells |
| 05/03/2000 | EP0625055B1 Use of fullerenes in diagnostic and/or therapeutic agents |
| 05/03/2000 | EP0563096B1 Novel methylenebisphosphonic acid derivatives |
| 05/03/2000 | CN1252099A Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
| 05/03/2000 | CN1252072A Carbapenem compounds, use and intermediate compounds thereof |
| 05/03/2000 | CN1252071A Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9H-purin-8-yl) phenyl derivatives, their preparation and use in treatment of inflammatory conditions and immune disorders |
| 05/03/2000 | CN1252070A 5,7-disubstituted 4-aminopyrido [2,3,-d] pyrimidine compounds and their use as adenosine kinase inhibitors |
| 05/03/2000 | CN1252069A 5,6,7-trisubstituted-4-aminopyrido [2,3-d] pyrimidine compounds |
| 05/03/2000 | CN1252068A 3-piperidyl-4-oxoquinazoline derivatives and medicinal compositions containing same |
| 05/03/2000 | CN1252064A Bicyclic amino acids |
| 05/03/2000 | CN1252063A 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors |
| 05/03/2000 | CN1252061A 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-thiones derivatives, their preparation and use as dopamine autoreceptor (D2) agonists |
| 05/03/2000 | CN1252060A 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives, their preparation and use as dopamine autoreceptor (D2) agonists |
| 05/03/2000 | CN1252058A Preparation of butylthio-isoquinoline and intermediate thereof |
| 05/03/2000 | CN1252057A 2-amino substituted pyridines for treating arteriosclerosis and hyperlipoproteinaemia |
| 05/03/2000 | CN1252053A Cetp activity inhibitors |
| 05/03/2000 | CN1252049A 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives |
| 05/03/2000 | CN1252006A Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes |
| 05/03/2000 | CN1252003A Solvent system for enhanced penetration of pharmaceutical compounds |
| 05/03/2000 | CN1252001A Method for destroying retinal pigment epithelial cells |
| 05/03/2000 | CN1252000A Pharmaceutical compositions having appetite suppressant activity |
| 05/03/2000 | CN1251998A Facililation of wound healing with CM101/GBS toxin |
| 05/03/2000 | CN1251997A Treatment of chronic inflammatory diseases with CM 101/GBS toxin |
| 05/03/2000 | CN1251996A Combination therapy for HIV infections |
| 05/03/2000 | CN1251995A Process for improving glucose metabolism, satiety, and nutrient absorption in companion animals |
| 05/03/2000 | CN1251994A Extended release formulations of erythromycin derivatives |
| 05/03/2000 | CN1251993A Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections |
| 05/03/2000 | CN1251992A Sulfated oligosacharides having anticoagulant/antithrombotic activity |
| 05/03/2000 | CN1251991A Carboxylic acid derivatives, their preparation and use in treating cancer |
| 05/03/2000 | CN1251990A Pharmaceutical formulations comprising amoxocyllin and clavulanate |
| 05/03/2000 | CN1251989A Methods and compositions for preventing and treating chronological aging in human skin |
| 05/03/2000 | CN1251987A Dasage forms comprising separate portions of R- and S-enantiomers |
| 05/03/2000 | CN1251986A Diffusional implantable delivery system |
| 05/03/2000 | CN1251979A Controlled release of pharmaceuticals in antiterior chamber of eye |
| 05/03/2000 | CN1251969A Method for treating parillomarvirus infections |
| 05/03/2000 | CN1251837A Preparation of steriod esters |
| 05/03/2000 | CN1251836A Preparation of intermediate for monocyclic beta-lactams derivatives |
| 05/03/2000 | CN1251773A Composition having silicone rubber stabilized ascorbic acid components |
| 05/03/2000 | CN1251770A Medicinal composition for treating anorectal cancer and its preparing process |
| 05/03/2000 | CN1251769A Ointment for treating burn and scald |
| 05/03/2000 | CN1251767A Chinese medicine and Western medicine compounded preparation for dropping drug |
| 05/03/2000 | CN1251758A Oral medicinal preparation |
| 05/03/2000 | CN1251745A Carotenoid preparation having mixture of beta-carotene, lycopene and xanthophyll |
| 05/03/2000 | CN1052035C Treatment of yeast paste contaminated by acid bacteria |
| 05/03/2000 | CN1052010C Benzimidazole derivatives, preparation and use thereof and medicines containing same |
| 05/03/2000 | CN1052009C Platium complex and maligant tumor treating drug containing same |
| 05/03/2000 | CN1052007C Anti-tanning agent, and light-protection cosmetic composition containing said agent and application thereof |
| 05/03/2000 | CN1052006C Vasocontrictive dihydrobenzopyran derivatives, preparation and use thereof |
| 05/03/2000 | CN1052005C Imidazopyridines and preparation and use thereof as medicines |
| 05/03/2000 | CN1052004C Heterocyclic compounds, their production and use |
| 05/03/2000 | CN1052003C Prodrugs of antiinflammatory 3-acyl-2-oxidole-1-carboxamides |
| 05/03/2000 | CN1052002C 4-aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans, preparation thereof and medicinal composition comprising them |
| 05/03/2000 | CN1051998C Isoquinolines preparation thereof and its medicinal compositions |
| 05/03/2000 | CN1051991C Preparation of glutaric acid derivatives |
| 05/03/2000 | CN1051990C Method for preparing ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes |
| 05/03/2000 | CN1051932C Drug for acne and its preparation |
| 05/03/2000 | CN1051931C Compound preparation for nutritional iron-deficiency anemia |
| 05/03/2000 | CN1051924C Emulsive medicine for dam's acyesis and production thereof |
| 05/03/2000 | CN1051923C Topical dosage form |
| 05/03/2000 | CN1051922C Formulation comprising antibacterial substance and anticancer substance |
| 05/03/2000 | CN1051921C Methods of inhibiting imperfect tissue repair |
| 05/03/2000 | CN1051920C Medicinal composition for craniocerebral trauma and its syndrome |
| 05/02/2000 | US6057461 Diels alder reaction of naphthoquinone with diene |
| 05/02/2000 | US6057457 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 05/02/2000 | US6057454 1-oxo-1H-inden-2-yl-1H-imidazole-2-carboxylic acid intermediates |
| 05/02/2000 | US6057453 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups |
| 05/02/2000 | US6057451 Anti-herpesvirus compounds and methods for identifying, making and using same |
| 05/02/2000 | US6057450 Derivatives of pyroglutaminic acid preparation process and applications |
| 05/02/2000 | US6057448 Reaction of halosulfide with imidazole to produce sulfide substituted imidazole |
| 05/02/2000 | US6057446 Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds |
| 05/02/2000 | US6057445 Formation of carbon nitrogen bond, cyclization and halogenation |
| 05/02/2000 | US6057441 Cardiovascular disorders and gastrointestinal disorders |
| 05/02/2000 | US6057440 Process for preparing bis-indoly macrocycles |
| 05/02/2000 | US6057439 Epoxysteroids |
| 05/02/2000 | US6057437 Antisense nucleic acid compounds inhibiting vascular endothelial growth factor |
| 05/02/2000 | US6057432 CysS |
| 05/02/2000 | US6057373 Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists |
| 05/02/2000 | US6057372 Consisting of macrocyclic lactones or macrocyclic ketones; body deodorizers, suppression of pimples |
| 05/02/2000 | US6057371 Sigma receptor ligands and the use thereof |
| 05/02/2000 | US6057369 Use in the treatment of disease states associated with proteins that mediate cellular activity which are capable of being modulated by inhibiting a matrix metalloproteinase (mmp), tumor necrosis factor (tnf) or cyclic amp |
| 05/02/2000 | US6057368 Administering to primate pharmaceutical composition including gamma vinylgaba (vigabatrin) |
| 05/02/2000 | US6057367 Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses |
| 05/02/2000 | US6057366 Treating breast or ovarian cancer is disclosed by administering compound obtained from avocado plant |
| 05/02/2000 | US6057364 Fluoro-substituted adamantane derivatives |
| 05/02/2000 | US6057362 Protease inhibitors |
| 05/02/2000 | US6057361 Formulations and methods of reducing toxicity of antineoplastic agents |
| 05/02/2000 | US6057359 Spontaneously dispersible concentrates comprising esters of baccatin-III compounds having antitumor and antiviral activity |
| 05/02/2000 | US6057351 Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetic and pharmaceuticals |
| 05/02/2000 | US6057349 2-imidazoline, 2-oxazoline, 2-thiazoline, and 4-imidazole derivatives of methylphenyl, methoxphenyl, and aminophenyl alkylsulfonamides and ureas and their use |
| 05/02/2000 | US6057347 Comprising nonsteroidal antiinflammatory drug and compound that donates, transfers, or releases nitric oxide, elevates endogenous synthesis levels of nitric oxide, or is substrate for nitric oxide synthase |
| 05/02/2000 | US6057346 Inhibition of retroviral LTR promoters by calcium response modifiers |
| 05/02/2000 | US6057345 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists |
| 05/02/2000 | US6057344 Methods for treating hypertension, and angina using optically pure (-) amlodipine |
| 05/02/2000 | US6057343 Have superior hypoglycemic and hypolipidemic actions and are useful for the treatment of diabetes and the complications thereof, as well as therapeutic agents for related diseases such as hyperlipidemia |
| 05/02/2000 | US6057341 Bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics |
| 05/02/2000 | US6057339 Method of inhibiting or treating phytosterolemia with an MTP inhibitor |